Literature DB >> 25478508

Effect of Angiotensin II Type 1 Receptor Antagonist, Losartan on Inflammatory Factor in Atherosclerotic Rabbits.

Yan-Min Xu1, Deepak Sharma1, Guang-Ping Li1, Ya-Nan Zhao1.   

Abstract

BACKGROUND: Atherosclerosis is a progressive disease characterized by the accumulation of lipids and fibrous elements in the large arteries which now has become the pre-eminent health problem worldwide.
OBJECTIVES: To investigate the effect and mechanism of Losartan intervention on atherosclerosis in rabbits fed with high-cholesterol diet.
MATERIALS AND METHODS: 32 New Zealand rabbits were randomly divided into three groups: control group, high-cholesterol group and Losartan group. The level of weights, serum lipid levels and inflammatory factors, such as IL-6 and hs C-reactive protein were detected before the Losartan intervention and two months after the Losartan intervention respectively. The content of AngII was detected on later stage of the experiment. Pathological examination of the iliac arteries was performed to measure the thickness of endothelium and media.
RESULTS: After the atherosclerosis model was established, the level of the serum lipids, hs CRP and IL-6 of rabbits in high-cholesterol group and Losartan group increased significantly in comparison with control group(P < 0.05), but there was no statistical difference between the two groups (P > 0.05). After the Losartan intervention, the levels of serum hs CRP and IL-6 were higher in high-cholesterol group and Losartan group in comparison with control group (P < 0.05), and they were significantly lower in Losartan group than high-cholesterol group (P < 0.05). Serum lipids levels of rabbits in high-cholesterol group and Losartan group also increased significantly in comparison with control group (P < 0.05), but there was no statistical difference between them (P > 0.05). Ratio of endothelium thickness to the media thickness was higher in high-cholesterol group and Losartan group in comparison with control group (P < 0.05), and the ratio in Losartan group was significantly lower than high-cholesterol group (P < 0.05). Content of Angiotensin was higher in high-cholesterol group and Losartan group compared to control group, and there was no statistical difference between them.
CONCLUSIONS: The effect of Losartan on atherosclerosis is to prevent the development of atherosclerosis by inhibiting inflammatory process and may not be related to the lipid metabolism.

Entities:  

Keywords:  AngiotensinII; Atherosclerosis; C-reactive protein; Interleukin-6; Losartan

Year:  2013        PMID: 25478508      PMCID: PMC4253768          DOI: 10.5812/cardiovascmed.10781

Source DB:  PubMed          Journal:  Res Cardiovasc Med        ISSN: 2251-9572


  15 in total

1.  Atherosclerosis: the new view.

Authors:  Peter Libby
Journal:  Sci Am       Date:  2002-05       Impact factor: 2.142

2.  [Inflammation, atherosclerosis, classic cardiovascular risk factors, biostatistics, clinical significance. Where are we?].

Authors:  Xavier García-Moll
Journal:  Rev Esp Cardiol       Date:  2007-12       Impact factor: 4.753

3.  [Upregulation of angiotensin-converting enzyme during the healing process after injury at the site of percutaneous transluminal coronary angioplasty in humans].

Authors:  M Ohishi; M Ueda; H Rakugi; A Okamura; T Naruko; A E Becker; K Hiwada; A Kamitani; K Kamide; J Higaki; T Ogihara
Journal:  J Cardiol       Date:  1998-03       Impact factor: 3.159

4.  Angiotensin II-induced hypertension accelerates the development of atherosclerosis in apoE-deficient mice.

Authors:  D Weiss; J J Kools; W R Taylor
Journal:  Circulation       Date:  2001-01-23       Impact factor: 29.690

5.  Role of angiotensin II type 1 receptor in the regulation of cellular adhesion molecules in atherosclerosis.

Authors:  A Prasad; K K Koh; W H Schenke; R Mincemoyer; G Csako; T A Fleischer; M Brown; T A Selvaggi; A A Quyyumi
Journal:  Am Heart J       Date:  2001-08       Impact factor: 4.749

6.  Angiotensin induces inflammatory activation of human vascular smooth muscle cells.

Authors:  R Kranzhöfer; J Schmidt; C A Pfeiffer; S Hagl; P Libby; W Kübler
Journal:  Arterioscler Thromb Vasc Biol       Date:  1999-07       Impact factor: 8.311

7.  Losartan inhibited expression of matrix metalloproteinases in rat atherosclerotic lesions and angiotensin II-stimulated macrophages.

Authors:  Chun Liang; Zong-gui Wu; Jian Ding; Jian-fei Jiang; Gao-zhong Huang; Rong-zeng Du; Jun-bo Ge
Journal:  Acta Pharmacol Sin       Date:  2004-11       Impact factor: 6.150

8.  Increased accumulation of tissue ACE in human atherosclerotic coronary artery disease.

Authors:  F Diet; R E Pratt; G J Berry; N Momose; G H Gibbons; V J Dzau
Journal:  Circulation       Date:  1996-12-01       Impact factor: 29.690

9.  Comparison of effects of amlodipine and angiotensin receptor blockers on the intima-media thickness of carotid arterial wall (AAA study: amlodipine vs. ARB in atherosclerosis study).

Authors:  Hiroki Ikeda; Jun Minamikawa; Yoshio Nakamura; Sachiko Honjo; Yoshiyuki Hamamoto; Yoshiharu Wada; Kouichiro Nabe; Hiroyuki Koshiyama
Journal:  Diabetes Res Clin Pract       Date:  2008-12-12       Impact factor: 5.602

Review 10.  The potential role of AT(1)-receptor blockade in the prevention and reversal of atherosclerosis.

Authors:  V Papademetriou
Journal:  J Hum Hypertens       Date:  2002-08       Impact factor: 3.012

View more
  4 in total

1.  Impact of losartan and angiotensin II on the expression of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in rat vascular smooth muscle cells.

Authors:  Yan-Song Guo; Zong-Gui Wu; Jun-Ke Yang; Xin-Jing Chen
Journal:  Mol Med Rep       Date:  2014-11-14       Impact factor: 2.952

2.  Decatecholaminization and calcium sensitizers in critically ill patients.

Authors:  Samad E J Golzari; Ata Mahmoodpoor
Journal:  Res Cardiovasc Med       Date:  2014-02-24

3.  Valsartan decreases platelet activity and arterial thrombotic events in elderly patients with hypertension.

Authors:  Fang Wu; Hong-Yan Wang; Fan Cai; Ling-Jie Wang; Feng-Ru Zhang; Xiao-Nan Chen; Qian Yang; Meng-Hui Jiang; Xue-Feng Wang; Wei-Feng Shen
Journal:  Chin Med J (Engl)       Date:  2015-01-20       Impact factor: 2.628

4.  The Effects of Angiotensin II or Angiotensin 1-7 on Rat Pial Microcirculation during Hypoperfusion and Reperfusion Injury: Role of Redox Stress.

Authors:  Dominga Lapi; Maurizio Cammalleri; Massimo Dal Monte; Martina Di Maro; Mariarosaria Santillo; Anna Belfiore; Gilda Nasti; Simona Damiano; Rossella Trio; Martina Chiurazzi; Barbara De Conno; Nicola Serao; Paolo Mondola; Antonio Colantuoni; Bruna Guida
Journal:  Biomolecules       Date:  2021-12-10
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.